Connect with us

Health

Vir Biotechnology Announces New Research Demonstrating Novel Mechanisms by Which SARS-CoV-2 Enters Host Cells – GlobeNewswire

– Growing body of evidence suggests monoclonal antibodies that target a conserved epitope have the potential to be highly effective against SARS-CoV-2…

Published

on

Growing body of evidence suggests monoclonal antibodies that target a conserved epitope have the potential to be highly effective against SARS-CoV-2 and associated known mutations
Newly identified cell surface proteins play a role in SARS-CoV-2 infection and determine how certain classes of antibodies work
SAN FRANCISCO, April 08, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the publication of new preclinical research highlighting novel mechanisms by which SARS-CoV-2…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Scientists probe mystery of ‘thunderstorm asthma’ event that sent thousands to the ER – Livescience.com
Article feature image
Key biomarker for inflammation and COVID-19 risk – Medical Xpress